Renal
circa 1550 BCE, Ancient Egypt (Ebers Papyrus, general kidney and urinary disorder descriptions); specific entity identified 1968, France (Berger and Hinglais, Necker Hospital)
IgA nephropathy, later recognized as the most common form of primary glomerulonephritis worldwide, was a condition whose underlying immunological mechanisms remained entirely invisible to physicians for most of medical history. Early healers attributed its characteristic signs to humoral imbalances, kidney weakness, or constitutional disorders. The condition's true identity was not established until the latter half of the twentieth century, when advances in biopsy techniques and immunofluorescence microscopy allowed researchers to peer directly into kidney tissue.
Historical Narrative
For much of recorded medical history, kidney disease was understood through the lens of the four humors, a framework inherited from Greek antiquity and transmitted through centuries of Islamic and European scholarship. Ancient Egyptian physicians, working from observations recorded in the Ebers Papyrus around 1550 BCE, noted conditions involving dark or discolored urine and associated such signs with disturbances of internal organs, though no specific understanding of the kidney's filtering role yet existed. Greek physicians including Hippocrates described what they called nephritis in broad terms, attributing swelling and urinary changes to an excess of phlegm or a corruption of the blood passing through the renal organs.
Galen of Pergamon, working in the second century CE, elaborated a more detailed anatomical model of the kidneys, arguing that they actively separated waste from the blood. His framework, though wrong in many particulars, dominated European medical thinking for over a millennium and shaped how physicians interpreted any disorder involving the urine. Medieval Islamic physicians such as Avicenna, whose Canon of Medicine became a foundational text across both Islamic and European universities, discussed kidney ailments in terms of temperament and recommended herbal and dietary regimens aimed at restoring humoral balance.
The early modern period brought the first systematic efforts to correlate post-mortem anatomical findings with disease presentation during life. Thomas Willis in the seventeenth century and Richard Bright in the nineteenth century made landmark contributions to the understanding of kidney disease as a distinct pathological entity. Bright's 1827 reports, published after he examined patients at Guy's Hospital in London and then correlated their clinical histories with post-mortem kidney specimens, established the category of what became known as Bright's disease, a broad umbrella that captured many forms of kidney inflammation. His work represented the first serious attempt to link observable kidney tissue changes with the course of illness, and it prompted generations of subsequent researchers to pursue finer distinctions within that category.
Through the late nineteenth and early twentieth centuries, pathologists began developing more precise classifications of kidney disease, gradually distinguishing glomerulonephritis from other forms of renal injury. The invention and refinement of the percutaneous kidney biopsy technique in the mid-twentieth century, pioneered by researchers including Nils Alwall in Sweden and Poul Iversen and Claus Brun in Denmark during the 1940s and 1950s, transformed nephrology by making it possible to examine kidney tissue from living patients. This opened the door to systematic microscopic classification of kidney diseases in ways that post-mortem examination alone had never permitted.
The specific entity later called IgA nephropathy was identified by French pathologist Jean Berger and his colleague Nicole Hinglais in 1968, working at the Necker Hospital in Paris. Using immunofluorescence techniques, they observed deposits of immunoglobulin A within the mesangial cells of the glomeruli in kidney biopsy specimens. Berger published these findings, and the condition was subsequently referred to as Berger's disease in his honor, particularly in European medical literature. His identification of a specific immunoglobulin class as the defining pathological feature marked a turning point in the classification of kidney disease, shifting the field from purely structural descriptions toward immunological characterization. In the decades following Berger's discovery, researchers across Japan, Australia, and Europe documented the condition's global prevalence and began investigating the role of mucosal immunity in its development.
Key Historical Figures
Historical narrative only — this page describes how IgA nephropathy was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.